Substituted benzopyrans as selective estrogen receptor-beta agonists
    8.
    发明授权
    Substituted benzopyrans as selective estrogen receptor-beta agonists 失效
    取代的苯并吡喃作为选择性雌激素受体-β激动剂

    公开(公告)号:US07354951B2

    公开(公告)日:2008-04-08

    申请号:US11574034

    申请日:2005-10-05

    IPC分类号: A61K31/353 C07D311/78

    CPC分类号: C07D311/94

    摘要: The present invention relates to novel benzopyran ER-β agonist compounds, pharmaceutical compositions thereof, and use of these compounds to treat a ER-β mediated disease such as nocturia, obstructive uropathy, benign prostatic hypertrophy, obesity, dementia, hypertension, incontinence, colon cancer, prostate cancer, infertility, depression, leukemia, inflammatory bowel disease, and arthritis. Formula (I), wherein G is —O—, —S(O)n, —CF2—, —C(O)—, —CR1H— or —CR2(OH)—; R is halo, (C1-C4)alkyl or R3—(CH2)m—; R1 is F, hydroxyl, cyano, trifluoromethyl, (C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkylcarbonyloxy or benzyl; R2 is trifluoromethyl or (C1-C4)alkyl; R3 is cyano, hydroxyl, (C2-C4)alkenyl, (C1-C4)alkoxy or (C1-C4)alkoxycarbonyl; n is 0, 1 or 2; and m is 0, 1 or 2; and pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明涉及新颖的苯并吡喃ER-β激动剂化合物,其药物组合物,以及这些化合物用于治疗ER-β介导的疾病如夜尿症,阻塞性尿病,良性前列腺肥大,肥胖,痴呆,高血压,失禁,结肠 癌症,前列腺癌,不育症,抑郁症,白血病,炎性肠病和关节炎。 式(I)其中G为-O-,-S(O)n,-CF 2 - , - C(O) - , - CR 1 H或-CR 2(OH) - ; R是卤素,(C 1 -C 4 - )烷基或R 3 - (CH 2 CH 2) m - ; R 1是F,羟基,氰基,三氟甲基,(C 1 -C 4 - )烷基,(C 1 -C 4)烷基, (C 1 -C 4) - 炔基,(C 1 -C 4) - 炔基,(C 1 -C 4 - (C 1 -C 4)烷基羰基氧基或苄基;(C 1 -C 4)烷基, R 2是三氟甲基或(C 1 -C 4 -C 4)烷基; R 3是氰基,羟基,(C 1 -C 4 -C 4)烯基,(C 1 -C 4 - (C 1 -C 4)烷氧基或(C 1 -C 4 -C 4)烷氧基羰基; n为0,1或2; m为0,1或2; 及其药学上可接受的盐。